measuregroup/AID36592

Predicate	Object
has specified output	http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103177869_AID36592_PMID2863377_VALUE1 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103177939_AID36592_PMID2863377_VALUE3 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103177907_AID36592_PMID2863377_VALUE2 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103676669_AID36592_PMID2863377_VALUE4
has participant	http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP15823 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP23944 http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1851 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP43140
source	http://rdf.ncbi.nlm.nih.gov/pubchem/source/ChEMBL
title	Ability to inhibit 50% specific binding of [3H]prazosin radioligand to alpha-1 adrenergic receptor in rat cerebrocortex
type	http://www.bioassayontology.org/bao#BAO_0000040

Predicate	Subject
participates in	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103177869 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103676669 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103177939 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103177907
has measure group	http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID36592

Total number of triples: 16.